NextTrip (NTRP) 10-Q 14 Aug 23 2023 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2023	Aug. 11, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2023
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	001-38015
Entity Registrant Name	SIGMA ADDITIVE SOLUTIONS, INC.
Entity Central Index Key	0000788611
Entity Tax Identification Number	27-1865814
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	3900 Paseo del Sol
Entity Address, City or Town	Santa Fe
Entity Address, State or Province	NM
Entity Address, Postal Zip Code	87507
City Area Code	(505)
Local Phone Number	438-2576
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	SASI
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		10,772,713

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current Assets:
Cash	$ 368,443	$ 2,845,931
Accounts Receivable, net	45,454	371,620
Inventory	940,034	950,943
Prepaid Assets	137,105	105,226
Total Current Assets	1,491,036	4,273,720
Other Assets:
Property and Equipment, net	227,787	304,903
Intangible Assets, net	1,215,411	1,125,285
Total Other Assets	1,443,198	1,430,188
TOTAL ASSETS	2,934,234	5,703,908
Current Liabilities:
Accounts Payable	300,562	277,492
Deferred Revenue	127,188	120,073
Accrued Expenses	115,195	231,633
Total Current Liabilities	542,945	629,198
TOTAL LIABILITIES	542,945	629,198
Commitments & Contingencies
Stockholders’ Equity
Preferred Stock, $0.001 par value; 10,000,000 shares authorized; 316 and 465 shares issued and outstanding, respectively	1	1
Common Stock, $ 0.001 par value; 24,000,000 shares authorized; 10,772,713 and 10,498,802 shares issued and outstanding, respectively	10,773	10,499
Additional Paid-In Capital	54,904,792	54,406,694
Accumulated Deficit	(52,524,277)	(49,342,484)
Total Stockholders’ Equity	2,391,289	5,074,710
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 2,934,234	$ 5,703,908

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	316	465
Preferred stock, shares outstanding	316	465
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	24,000,000	24,000,000
Common stock, shares issued	10,772,713	10,498,802
Common stock, shares outstanding	10,772,713	10,498,802

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
REVENUES	$ 97,043	$ 236,660	$ 227,202	$ 288,504
COST OF REVENUE	36,491	193,075	100,155	233,166
GROSS PROFIT	60,552	43,585	127,047	55,338
OPERATING EXPENSES:
Salaries & Benefits	554,182	1,184,818	1,485,764	2,476,828
Stock-Based Compensation	138,489	167,439	363,339	338,415
Operations and R&D Costs	105,259	146,885	231,971	290,303
Investor, Public Relations and Marketing	57,824	152,300	112,768	246,626
Organization Costs	38,240	60,817	89,438	119,566
Legal & Professional Service Fees	152,025	144,528	336,276	355,944
Office Expenses	94,190	303,600	248,689	509,032
Depreciation & Amortization	21,470	29,861	49,597	61,445
Other Operating Expenses	202,892	89,177	294,873	176,964
Total Operating Expenses	1,364,571	2,279,425	3,212,715	4,575,123
LOSS FROM OPERATIONS	(1,304,019)	(2,235,840)	(3,085,668)	(4,519,785)
OTHER INCOME (EXPENSE)
Interest Income	9	1,176	17	2,747
State Incentives				76,628
Exchange Rate Gain (Loss)	(849)	(10,436)	(3,352)	(10,766)
Interest Expense	(3,235)	(2,070)	(6,471)	(3,389)
Other Income			35,680
Total Other Income (Expense)	(4,075)	(11,330)	25,874	65,220
LOSS BEFORE PROVISION FOR INCOME TAXES	(1,308,094)	(2,247,170)	(3,059,794)	(4,454,565)
Provision for income Taxes
Net Loss	(1,308,094)	(2,247,170)	(3,059,794)	(4,454,565)
Preferred Dividends	(10,688)	(14,220)	(22,435)	(28,440)
Net Loss Applicable to Common Stockholders	$ (1,318,782)	$ (2,261,390)	$ (3,082,229)	$ (4,483,005)
Net Loss per Common Share – Basic	$ (0.12)	$ (0.22)	$ (0.29)	$ (0.43)
Net Loss per Common Share - Diluted	$ (0.12)	$ (0.22)	$ (0.29)	$ (0.43)
Weighted Average Number of Shares Outstanding – Basic	10,772,713	10,498,802	10,731,922	10,498,802
Weighted Average Number of Shares Outstanding - Diluted	10,772,713	10,498,802	10,731,922	10,498,802

Statement of Stockholders' Equi

Statement of Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balances at Dec. 31, 2021	$ 1	$ 10,499	$ 53,442,431	$ (40,593,180)	$ 12,859,751
Balance, shares at Dec. 31, 2021	465	10,498,802
Net Loss				(4,454,565)	(4,454,565)
Preferred Stock Dividends			28,440	(28,440)
Stock Options Awarded to Directors for Services			43,442		43,442
Stock Options Issued for Third Party Services			23,490		23,490
Stock Options Awarded to Employees			338,415		338,415
Stock Options Issued for Third Party Services			(23,490)		(23,490)
Balances at Jun. 30, 2022	$ 1	$ 10,499	53,876,218	(45,076,185)	8,810,533
Balance, shares at Jun. 30, 2022	465	10,498,802
Balances at Mar. 31, 2022	$ 1	$ 10,499	53,661,061	(42,814,795)	10,856,766
Balance, shares at Mar. 31, 2022	465	10,498,802
Net Loss				(2,247,170)	(2,247,170)
Preferred Stock Dividends			14,220	(14,220)
Stock Options Awarded to Directors for Services			21,721		21,721
Stock Options Issued for Third Party Services			11,777		11,777
Stock Options Awarded to Employees			167,439		167,439
Stock Options Issued for Third Party Services			(11,777)		(11,777)
Balances at Jun. 30, 2022	$ 1	$ 10,499	53,876,218	(45,076,185)	8,810,533
Balance, shares at Jun. 30, 2022	465	10,498,802
Balances at Dec. 31, 2022	$ 1	$ 10,499	54,406,694	(49,342,484)	5,074,710
Balance, shares at Dec. 31, 2022	465	10,498,802
Net Loss				(3,059,794)	(3,059,794)
Preferred Stock Dividends		44	22,391	(22,435)
Stock Options Awarded to Directors for Services			13,523		13,523
Stock Options Issued to Employees			363,339		363,339
Stock Options Issued for Third Party Services			489		489
Preferred Stock Dividends, shares		43,896
Common Shares Issued for Conversion of Preferred Stock		$ 230	(230)
Common Shares Issued for Conversion of Preferred Stock, shares	(149)	230,015
Common Warrant Issued for Conversion of Preferred Stock			99,564	(99,564)
Stock Options Issued for Third Party Services			(489)		(489)
Balances at Jun. 30, 2023	$ 1	$ 10,773	54,904,792	(52,524,277)	2,391,289
Balance, shares at Jun. 30, 2023	316	10,772,713
Balances at Mar. 31, 2023	$ 1	$ 10,773	54,749,821	(51,205,495)	3,555,100
Balance, shares at Mar. 31, 2023	316	10,772,713
Net Loss				(1,308,094)	(1,308,094)
Preferred Stock Dividends			10,688	(10,688)
Stock Options Awarded to Directors for Services			5,794		5,794
Stock Options Issued to Employees			138,489		138,489
Balances at Jun. 30, 2023	$ 1	$ 10,773	$ 54,904,792	$ (52,524,277)	$ 2,391,289
Balance, shares at Jun. 30, 2023	316	10,772,713

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
OPERATING ACTIVITIES
Net Loss	$ (3,059,794)	$ (4,454,565)
Noncash Expenses:
Depreciation and Amortization	49,597	61,445
Change in assets and liabilities:
Accounts Receivable	326,166	120,434
Inventory	10,909	(73,586)
Prepaid Assets	(31,879)	(17,197)
Accounts Payable	23,070	33,958
Deferred Revenue	7,115	(18,151)
Accrued Expenses	(116,438)	(372,188)
NET CASH USED IN OPERATING ACTIVITIES	(2,414,881)	(4,314,503)
INVESTING ACTIVITIES
Purchase of Property and Equipment	42,516	(83,848)
Purchase of Intangible Assets	(105,123)	(115,197)
NET CASH USED IN INVESTING ACTIVITIES	(62,607)	(199,045)
FINANCING ACTIVITIES
NET CASH PROVIDED BY FINANCING ACTIVITIES
NET CHANGE IN CASH FOR PERIOD	(2,477,488)	(4,513,548)
CASH AT BEGINNING OF PERIOD	2,845,931	11,447,047
CASH AT END OF PERIOD	368,443	6,933,499
Noncash investing and financing activities disclosure:
Preferred Stock Dividends	22,435	28,440
Conversion of Preferred Shares to Common Shares	188,830
Other noncash operating activities disclosure:
Issuance of Securities for Services	13,034	66,932
Disclosure of cash paid for:
Interest	6,471	3,389
Income Taxes
Employees [Member]
Noncash Expenses:
Stock Based Compensation	363,339	338,415
Third Party Services [Member]
Noncash Expenses:
Stock Based Compensation	(489)	23,490
Director [Member]
Noncash Expenses:
Stock Based Compensation	$ 13,523	$ 43,442

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 1 - Summary of Significant Accounting Policies Nature of Business Basis of Presentation Going Concern As reported in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 20, 2023, the Company estimates that it has sufficient cash and working capital to fund its scaled-back operations as described below through August 2023 only. Since June 30, 2023, the Company has reduced its employee headcount to five, discontinued all product development activities and ceased to pursue new customers while continuing to consider a possible reverse merger, sale of the company or all or a portion of its assets, and other alternatives. Except for possible sales of shares of our common stock under the At-The-Market Issuance Sales Agreement described in Note 5- Subsequent Events, we have no agreement or arrangement to obtain any financing. There is no assurance that we will be able to enter into a definitive agreement with respect to a possible transaction or sell the Company or any of its assets or, if so, when or on what terms. If we fail to complete the sale of the Company or its assets or shares of common stock or obtain additional financing, we will be forced to resort to the dissolution and liquidation or bankruptcy of the Company. For these reasons, there is substantial doubt about our ability to continue as a going concern. Fair Value of Financial Instruments The Company does not use derivative instruments for hedging market risk or for trading or speculative purposes. Loss Per Share Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share June 30, 2023 2022 Warrants 2,902,089 3,825,781 Stock Options 1,897,659 1,528,637 Preferred Stock 60,332 148,918 Total Underlying Common Shares 4,860,080 5,503,336 The following table shows the amounts used in computing loss per share and the effect on net loss and the weighted average number of potentially dilutive shares for the periods shown: Schedule of Computing Loss Per Share Three Months Ended Six Months Ended 2023 2022 2023 2022 Net Loss per Common Share - Basic and Diluted $ (0.12 ) $ (0.22 ) $ (0.29 ) $ (0.43 ) Net Loss per Common Share - Basic $ (0.12 ) $ (0.22 ) $ (0.29 ) $ (0.43 ) Loss Applicable to Common Stockholders (numerator) $ (1,318,782 ) $ (2,261,390 ) $ (3,082,229 ) $ (4,483,005 ) Weighted Average Number of Common Shares Outstanding Used in Loss Per Share During the Period (denominator) 10,772,713 10,498,802 10,731,922 10,498,802 Accounting Estimates Leases Long-Lived and Intangible Assets 17 Revenue Recognition Revenue from Contracts with Customers In January 2022, the Company began offering a subscription option to its customers pursuant to which it leases its PrintRite3D platform for terms of between 12 and 36 months and provide technical support and maintenance for the term of the arrangement, as well as installation and training. The Company has determined these are leases because they relate to discrete pieces of equipment to which customers have the right to substantially all the economic benefit and exclusive use during the term of the arrangement. These leases are classified as operating leases and the Company retains title to the underlying equipment. The leases may be renewed for successive one-year terms unless notice is given by either party of its intent not to renew at least 30 days before the end of the lease term. For leases with 36-month terms, the lessee may terminate the agreement after the first 18 months upon at least 30 days written notice. Some, but not all, of the leases permit lessees to purchase the equipment at any time at an amount that approximates fair value and are not reasonably certain to be exercised at the inception of the lease. There are no anticipated variable lease payments at the inception of the lease. There are two non-lease components in the arrangement that consist of technical support and maintenance, and installation and training, respectively. The Company has elected single component practical expedient accounting to combine the technical support and maintenance with the lease as they have the same pattern of transfer. The installation and training component does not have the same pattern of transfer; therefore, this component is not eligible for single component practical expedient accounting. The consideration has been allocated on a relative fair value basis of the underlying lease and non-lease components. The Company has estimated the residual value of the leased equipment based on its useful life, and the ability to refurbish and sell the equipment, as well as the Company’s ability to componentize the hardware and utilize subassemblies in other products. Revenue from these operating leases for the three and six months ended June 30, 2023 was $ 11,337 28,343 Accounts Receivable and Allowance for Doubtful Accounts 115,600 0 Minimum Lease Payments Receivable Minimum lease payments receivable for the succeeding years ending December 31 are as follows: Schedule of Minimum Lease Payments Receivable Year ending December 31, Amount 2023 (remaining) $ 17,006 2024 8,503 2025 - 2026 - Thereafter - Total $ 25,509 Equipment Underlying Operating Leases: Equipment under operating leases as of June 30, 2023 was comprised of the following: Schedule of Assets underlying Operating Leases June 30, 2023 PrintRite3D Hardware $ 77,208 Accumulated Depreciation (12,445 ) Net Book Value $ 64,763 The Company is depreciating the underlying equipment over its useful life of 7

Inventory

Inventory	6 Months Ended
	Jun. 30, 2023
Inventory Disclosure [Abstract]
Inventory	NOTE 2 – Inventory At June 30, 2023 and December 31, 2022, the Company’s inventory was comprised of the following: Schedule of Inventory June 30, 2023 December 31, 2022 Raw Materials $ 257,714 $ 294,194 Work in Process 165,777 140,723 Finished Goods 516,543 516,026 Total Inventory $ 940,034 $ 950,943

Intangible Assets

Intangible Assets	6 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	NOTE 3 – Intangible Assets The Company’s intangible assets consist of patents and patent applications. The Company capitalizes costs incurred in connection with acquiring its patents. These costs include registration, documentation, and legal fees associated with the application. Costs incurred with patents that have been previously granted are expensed as incurred. Provisional patent applications are not amortized until a patent has been granted. Once a patent is granted, the Company will amortize the related costs over the estimated useful life of the patent. If a patent application is denied, then the costs will be expensed at that time. During the six months ended June 30, 2023, $ 27,571 The following is a summary of definite-life intangible assets less accumulated amortization as of June 30, 2023 and December 31, 2022, respectively: Summary of Definite-life Intangible Assets and Accumulated Amortization June 30, December 31, Provisional Patent Applications $ 752,802 $ 675,251 Patents 552,321 524,750 Less: Accumulated Amortization (89,712 ) (74,716 ) Net Intangible Assets $ 1,215,411 $ 1,125,285 Amortization expense on intangible assets was $ 14,996 10,993 The estimated aggregate amortization expense for years ending December 31 is as follows: Schedule of Aggregate Amortization Expense 2023 (Remaining) $ 15,596 2024 31,192 2025 31,192 2026 31,192 Thereafter 353,437 Intangible asset and amortization expense $ 462,609

Stockholders_ Equity

Stockholders’ Equity	6 Months Ended
	Jun. 30, 2023
Equity [Abstract]
Stockholders’ Equity	NOTE 4 - Stockholders’ Equity Common Stock In the second quarter of 2023, the Company did not issue any shares of common stock. In the first quarter of 2023, the Company issued 227,587 132 43,241 Also in the first quarter of 2023, the Company issued 2,428 17 655 Preferred Stock The Company is authorized to issue 10,000,000 0.001 316 465 In January 2020, the Company entered into a Securities Purchase Agreement with certain institutional investors (the “Institutional Private Placement”), pursuant to which the Company issued and sold 1,640 1,000 9 0.58 On January 27, 2023, the holder of the remaining 132 270,828 At June 30, 2023, there were no Concurrent with the Institutional Private Placement, the Company entered into a Securities Purchase Agreement pursuant to which the Company issued and sold to certain of its directors and the Company’s then largest stockholder 333 1,000 9 48,544 On January 23, 2023, the holder of 17 3,083 At June 30, 2023, 316 60,332 Stock Options The Company’s 2013 Equity Incentive Plan expired on March 15, 2023. As such, there were no On January 26, 2023, the Company granted options to its non-employee directors to purchase up to an aggregate of 52,380 0.58 50 50 On January 26, 2023, the Company granted 19 employees options to purchase up to an aggregate of 381,285 0.58 50 50 The Company generally grants stock options to employees and directors at exercise prices equal to the fair market value of the Company’s common stock on the grant date, but not less than 100% of the fair market value. Stock options are typically granted throughout the year and generally vest over a period from one to three years of service and expire five years from the grant date, unless otherwise specified. The Company recognizes compensation expense for the fair value of the stock options over the vesting period for each stock option award. Total stock-based compensation expense included in the statements of operations for the six months ended June 30, 2023 and 2022 was $ 363,339 338,415 The fair value of stock-based awards was estimated using the Black-Scholes model with the following weighted average assumptions for the six months ended June 30, 2023, and 2022: Schedule of Share Based Payments Award Stock Options Valuation Assumptions 2023 2022 Dividend yield 0.00 % 0.00 % Risk-free interest rate 4.05 % 0.95 1.65 % Expected volatility 100.23 100.25 % 106.4 110.0 % Expected life (in years) 5 5 Option activity for the six months ended June 30, 2023 and the year ended December 31, 2022 was as follows: Schedule of Share Based Compensation Stock Option Activity Options Weighted Weighted Aggregate Options outstanding at December 31, 2021 1,395,882 4.24 3.89 - Granted 487,473 2.50 4.43 - Exercised - - - - Forfeited or cancelled (84,302 ) 4.39 - - Options outstanding at December 31, 2022 1,799,053 3.76 3.30 - Granted 433,665 0.58 4.58 - Exercised - - - - Forfeited or cancelled (335,059 ) 3.60 - - Options outstanding at June 30, 2023 1,897,659 3.07 3.21 - Options expected to vest in the future as of June 30, 2023 409,974 1.93 4.03 - Options exercisable at June 30, 2023 1,487,685 3.38 2.98 - Options vested, exercisable, and options expected to vest at June 30, 2023 1,897,659 3.07 3.21 - The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the market price of our common stock for those awards that have an exercise price below the market price of our common stock. At June 30, 2023, no option had an exercise price below the $ 0.35 At June 30, 2023, there was $ 387,351 1.42 Stock Appreciation Rights On June 23, 2020, the board of directors (the “Board”) of the Company adopted the 2020 Stock Appreciation Rights Plan (the “Plan”). The purposes of the Plan are to: (i) enable the Company to attract and retain the types of employees, consultants, and directors (collectively, “Service Providers”) who will contribute to the Company’s long-range success; (ii) provide incentives that align the interests of Service Providers with those of the stockholders of the Company; and (iii) promote the success of the Company’s business. The Plan provides for incentive awards only in the form of stock appreciation rights payable in cash (“SARs”) and no shares of common stock are reserved or will be issued pursuant to the Plan. A SAR is the right to receive an amount equal to the Spread with respect to a share of the Company’s common stock (“Share”) upon the exercise of the SAR. The “Spread” is the difference between the exercise price per share specified in a SAR agreement on the date of grant and the fair market value per share on the date of exercise of the SAR. The exercise price per share will not be less than 100% of the fair market value of a share of common stock on the date of grant of the SAR. The administrator of the Plan will have the authority to, among other things, prescribe the terms and conditions of each SAR, including the exercise price and vesting provisions, and to specify the provisions of the SAR Agreement relating to such grant. The Company did not grant any SAR’s during the six months ended June 30, 2023. The Company recognizes compensation expense and a corresponding liability for the fair value of the SARs over the vesting period for each SAR award. The SARs are revalued at each reporting date in accordance with ASC 718 “Compensation-Stock Compensation,” and any changes in fair value are reflected in the Statement of Operations as of the applicable reporting date. The fair value of SAR awards was estimated using the Black-Scholes model with the following weighted average assumptions for the six months ended June 30, 2023 and the year ended December 31, 2022: Schedule of Share Based Payments Award Stock Options Valuation Assumptions 2023 2022 Dividend yield - 0.00 % Risk-free interest rate - 0.82 2.79 % Expected volatility - 108.0 119.0 % Expected life (in years) - 5 SARs activity for the six months ended June 30, 2023 and the year ended December 31, 2022 was as follows: Schedule of Stock Option Activity SARs Weighted Weighted Aggregate SARs outstanding at December 31, 2021 370,624 3.15 4.24 - Granted 814,862 1.81 4.48 - Exercised - - - - Forfeited or cancelled (27,699 ) 2.91 - - SARs outstanding at December 31, 2022 1,157,787 2.21 4.11 - Granted - - - - Exercised - - - - Forfeited or cancelled (328,822 ) 2.10 - - SARs outstanding June 30, 2023 828,965 2.26 3.63 - SARs expected to vest in the future as of June 30, 2023 530,678 2.02 3.85 - SARs exercisable at June 30, 2023 298,287 2.68 3.24 - SARs vested, and exercisable, and SARs expected to vest at June 30, 2023 828,965 2.26 3.63 - The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the market price of our common stock for those awards that have an exercise price below the market price of our common stock. At June 30, 2023, no SAR had an exercise price below the $ 0.35 At June 30, 2023, there was $ 474,228 1.75 Warrants Warrant activity for the six months ended June 30, 2023 and the year ended December 31, 2022 was as follows: Schedule of Warranty Activity Warrants Weighted Weighted Warrants outstanding at December 31, 2021 3,987,931 6.10 2.10 Granted - - - Exercised - - - Forfeited or cancelled (164,652 ) - - Warrants outstanding at December 31, 2022 3,823,279 4.66 1.19 Granted 1,490,896 0.58 2.62 Exercised - - - Forfeited or cancelled (2,412,086 ) 4.54 - Warrants outstanding at June 30, 2023 2,902,089 2.08 2.34

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	NOTE 5 - Subsequent Events In July 2023, the Company realized gross proceeds of approximately $ 135,000 On July 14, 2023, the employment of Stephan Kuehr, General Manager of European Operations, terminated. On August 14, 2023, the Company entered into an At-the-Market Issuance Sales Agreement (the “Sales Agreement”) with Lake Street Capital Markets, LLC, or Lake Street, pursuant to which the Company may issue and sell from time to time through Lake Street, as sales agent, shares of our common stock having an aggregate offering price of up to $ 1,500,000 Upon delivery of a placement notice, and subject to the terms and conditions of the Sales Agreement, Lake Street as sales agent may sell shares of common stock by methods deemed to be an “at the market offering” as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended. The sales agent is not required to purchase any shares of common stock from the Company or sell any specific number or dollar amount of common stock but will use its commercially reasonable efforts consistent with its normal trading and sales practices as our agent to sell shares of common stock in the Offering as instructed by us. The Company or Lake Street may suspend or terminate the Offering upon notice to the other and subject to other conditions. The Company has agreed to pay Lake Street a commission of 3.0

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Nature of Business	Nature of Business
Basis of Presentation	Basis of Presentation
Going Concern	Going Concern As reported in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 20, 2023, the Company estimates that it has sufficient cash and working capital to fund its scaled-back operations as described below through August 2023 only. Since June 30, 2023, the Company has reduced its employee headcount to five, discontinued all product development activities and ceased to pursue new customers while continuing to consider a possible reverse merger, sale of the company or all or a portion of its assets, and other alternatives. Except for possible sales of shares of our common stock under the At-The-Market Issuance Sales Agreement described in Note 5- Subsequent Events, we have no agreement or arrangement to obtain any financing. There is no assurance that we will be able to enter into a definitive agreement with respect to a possible transaction or sell the Company or any of its assets or, if so, when or on what terms. If we fail to complete the sale of the Company or its assets or shares of common stock or obtain additional financing, we will be forced to resort to the dissolution and liquidation or bankruptcy of the Company. For these reasons, there is substantial doubt about our ability to continue as a going concern.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company does not use derivative instruments for hedging market risk or for trading or speculative purposes.
Loss Per Share	Loss Per Share Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share June 30, 2023 2022 Warrants 2,902,089 3,825,781 Stock Options 1,897,659 1,528,637 Preferred Stock 60,332 148,918 Total Underlying Common Shares 4,860,080 5,503,336 The following table shows the amounts used in computing loss per share and the effect on net loss and the weighted average number of potentially dilutive shares for the periods shown: Schedule of Computing Loss Per Share Three Months Ended Six Months Ended 2023 2022 2023 2022 Net Loss per Common Share - Basic and Diluted $ (0.12 ) $ (0.22 ) $ (0.29 ) $ (0.43 ) Net Loss per Common Share - Basic $ (0.12 ) $ (0.22 ) $ (0.29 ) $ (0.43 ) Loss Applicable to Common Stockholders (numerator) $ (1,318,782 ) $ (2,261,390 ) $ (3,082,229 ) $ (4,483,005 ) Weighted Average Number of Common Shares Outstanding Used in Loss Per Share During the Period (denominator) 10,772,713 10,498,802 10,731,922 10,498,802
Accounting Estimates	Accounting Estimates
Leases	Leases
Long-Lived and Intangible Assets	Long-Lived and Intangible Assets 17
Revenue Recognition	Revenue Recognition Revenue from Contracts with Customers In January 2022, the Company began offering a subscription option to its customers pursuant to which it leases its PrintRite3D platform for terms of between 12 and 36 months and provide technical support and maintenance for the term of the arrangement, as well as installation and training. The Company has determined these are leases because they relate to discrete pieces of equipment to which customers have the right to substantially all the economic benefit and exclusive use during the term of the arrangement. These leases are classified as operating leases and the Company retains title to the underlying equipment. The leases may be renewed for successive one-year terms unless notice is given by either party of its intent not to renew at least 30 days before the end of the lease term. For leases with 36-month terms, the lessee may terminate the agreement after the first 18 months upon at least 30 days written notice. Some, but not all, of the leases permit lessees to purchase the equipment at any time at an amount that approximates fair value and are not reasonably certain to be exercised at the inception of the lease. There are no anticipated variable lease payments at the inception of the lease. There are two non-lease components in the arrangement that consist of technical support and maintenance, and installation and training, respectively. The Company has elected single component practical expedient accounting to combine the technical support and maintenance with the lease as they have the same pattern of transfer. The installation and training component does not have the same pattern of transfer; therefore, this component is not eligible for single component practical expedient accounting. The consideration has been allocated on a relative fair value basis of the underlying lease and non-lease components. The Company has estimated the residual value of the leased equipment based on its useful life, and the ability to refurbish and sell the equipment, as well as the Company’s ability to componentize the hardware and utilize subassemblies in other products. Revenue from these operating leases for the three and six months ended June 30, 2023 was $ 11,337 28,343
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable and Allowance for Doubtful Accounts 115,600 0 Minimum Lease Payments Receivable Minimum lease payments receivable for the succeeding years ending December 31 are as follows: Schedule of Minimum Lease Payments Receivable Year ending December 31, Amount 2023 (remaining) $ 17,006 2024 8,503 2025 - 2026 - Thereafter - Total $ 25,509 Equipment Underlying Operating Leases: Equipment under operating leases as of June 30, 2023 was comprised of the following: Schedule of Assets underlying Operating Leases June 30, 2023 PrintRite3D Hardware $ 77,208 Accumulated Depreciation (12,445 ) Net Book Value $ 64,763 The Company is depreciating the underlying equipment over its useful life of 7

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share	Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share June 30, 2023 2022 Warrants 2,902,089 3,825,781 Stock Options 1,897,659 1,528,637 Preferred Stock 60,332 148,918 Total Underlying Common Shares 4,860,080 5,503,336
Schedule of Computing Loss Per Share	The following table shows the amounts used in computing loss per share and the effect on net loss and the weighted average number of potentially dilutive shares for the periods shown: Schedule of Computing Loss Per Share Three Months Ended Six Months Ended 2023 2022 2023 2022 Net Loss per Common Share - Basic and Diluted $ (0.12 ) $ (0.22 ) $ (0.29 ) $ (0.43 ) Net Loss per Common Share - Basic $ (0.12 ) $ (0.22 ) $ (0.29 ) $ (0.43 ) Loss Applicable to Common Stockholders (numerator) $ (1,318,782 ) $ (2,261,390 ) $ (3,082,229 ) $ (4,483,005 ) Weighted Average Number of Common Shares Outstanding Used in Loss Per Share During the Period (denominator) 10,772,713 10,498,802 10,731,922 10,498,802
Schedule of Minimum Lease Payments Receivable	Minimum lease payments receivable for the succeeding years ending December 31 are as follows: Schedule of Minimum Lease Payments Receivable Year ending December 31, Amount 2023 (remaining) $ 17,006 2024 8,503 2025 - 2026 - Thereafter - Total $ 25,509
Schedule of Assets underlying Operating Leases	Equipment under operating leases as of June 30, 2023 was comprised of the following: Schedule of Assets underlying Operating Leases June 30, 2023 PrintRite3D Hardware $ 77,208 Accumulated Depreciation (12,445 ) Net Book Value $ 64,763

Inventory (Tables)

Inventory (Tables)	6 Months Ended
	Jun. 30, 2023
Inventory Disclosure [Abstract]
Schedule of Inventory	At June 30, 2023 and December 31, 2022, the Company’s inventory was comprised of the following: Schedule of Inventory June 30, 2023 December 31, 2022 Raw Materials $ 257,714 $ 294,194 Work in Process 165,777 140,723 Finished Goods 516,543 516,026 Total Inventory $ 940,034 $ 950,943

Intangible Assets (Tables)

Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Definite-life Intangible Assets and Accumulated Amortization	The following is a summary of definite-life intangible assets less accumulated amortization as of June 30, 2023 and December 31, 2022, respectively: Summary of Definite-life Intangible Assets and Accumulated Amortization June 30, December 31, Provisional Patent Applications $ 752,802 $ 675,251 Patents 552,321 524,750 Less: Accumulated Amortization (89,712 ) (74,716 ) Net Intangible Assets $ 1,215,411 $ 1,125,285
Schedule of Aggregate Amortization Expense	The estimated aggregate amortization expense for years ending December 31 is as follows: Schedule of Aggregate Amortization Expense 2023 (Remaining) $ 15,596 2024 31,192 2025 31,192 2026 31,192 Thereafter 353,437 Intangible asset and amortization expense $ 462,609

Stockholders_ Equity (Tables)

Stockholders’ Equity (Tables)	6 Months Ended
	Jun. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Share Based Payments Award Stock Options Valuation Assumptions	The fair value of stock-based awards was estimated using the Black-Scholes model with the following weighted average assumptions for the six months ended June 30, 2023, and 2022: Schedule of Share Based Payments Award Stock Options Valuation Assumptions 2023 2022 Dividend yield 0.00 % 0.00 % Risk-free interest rate 4.05 % 0.95 1.65 % Expected volatility 100.23 100.25 % 106.4 110.0 % Expected life (in years) 5 5
Schedule of Stock Option Activity	Option activity for the six months ended June 30, 2023 and the year ended December 31, 2022 was as follows: Schedule of Share Based Compensation Stock Option Activity Options Weighted Weighted Aggregate Options outstanding at December 31, 2021 1,395,882 4.24 3.89 - Granted 487,473 2.50 4.43 - Exercised - - - - Forfeited or cancelled (84,302 ) 4.39 - - Options outstanding at December 31, 2022 1,799,053 3.76 3.30 - Granted 433,665 0.58 4.58 - Exercised - - - - Forfeited or cancelled (335,059 ) 3.60 - - Options outstanding at June 30, 2023 1,897,659 3.07 3.21 - Options expected to vest in the future as of June 30, 2023 409,974 1.93 4.03 - Options exercisable at June 30, 2023 1,487,685 3.38 2.98 - Options vested, exercisable, and options expected to vest at June 30, 2023 1,897,659 3.07 3.21 -
Schedule of Warranty Activity	Warrant activity for the six months ended June 30, 2023 and the year ended December 31, 2022 was as follows: Schedule of Warranty Activity Warrants Weighted Weighted Warrants outstanding at December 31, 2021 3,987,931 6.10 2.10 Granted - - - Exercised - - - Forfeited or cancelled (164,652 ) - - Warrants outstanding at December 31, 2022 3,823,279 4.66 1.19 Granted 1,490,896 0.58 2.62 Exercised - - - Forfeited or cancelled (2,412,086 ) 4.54 - Warrants outstanding at June 30, 2023 2,902,089 2.08 2.34
Stock Appreciation Rights [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Share Based Payments Award Stock Options Valuation Assumptions	The fair value of SAR awards was estimated using the Black-Scholes model with the following weighted average assumptions for the six months ended June 30, 2023 and the year ended December 31, 2022: Schedule of Share Based Payments Award Stock Options Valuation Assumptions 2023 2022 Dividend yield - 0.00 % Risk-free interest rate - 0.82 2.79 % Expected volatility - 108.0 119.0 % Expected life (in years) - 5
Schedule of Stock Option Activity	SARs activity for the six months ended June 30, 2023 and the year ended December 31, 2022 was as follows: Schedule of Stock Option Activity SARs Weighted Weighted Aggregate SARs outstanding at December 31, 2021 370,624 3.15 4.24 - Granted 814,862 1.81 4.48 - Exercised - - - - Forfeited or cancelled (27,699 ) 2.91 - - SARs outstanding at December 31, 2022 1,157,787 2.21 4.11 - Granted - - - - Exercised - - - - Forfeited or cancelled (328,822 ) 2.10 - - SARs outstanding June 30, 2023 828,965 2.26 3.63 - SARs expected to vest in the future as of June 30, 2023 530,678 2.02 3.85 - SARs exercisable at June 30, 2023 298,287 2.68 3.24 - SARs vested, and exercisable, and SARs expected to vest at June 30, 2023 828,965 2.26 3.63 -

Schedule of Anti-dilutive Secur

Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total Underlying Common Shares	4,860,080	5,503,336
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total Underlying Common Shares	2,902,089	3,825,781
Equity Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total Underlying Common Shares	1,897,659	1,528,637
Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total Underlying Common Shares	60,332	148,918

Schedule of Computing Loss Per

Schedule of Computing Loss Per Share (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Accounting Policies [Abstract]
Net Loss per Common Share - Basic	$ (0.12)	$ (0.22)	$ (0.29)	$ (0.43)
Net Loss per Common Share - Diluted	$ (0.12)	$ (0.22)	$ (0.29)	$ (0.43)
Loss Applicable to Common Stockholders (numerator)	$ (1,318,782)	$ (2,261,390)	$ (3,082,229)	$ (4,483,005)
Weighted Average Number of Common Shares Outstanding Used in Loss Per Share During the Period (denominator)	10,772,713	10,498,802	10,731,922	10,498,802

Schedule of Minimum Lease Payme

Schedule of Minimum Lease Payments Receivable (Details)	Dec. 31, 2022 USD ($)
Accounting Policies [Abstract]
2023 (remaining)	$ 17,006
2024	8,503
2025
2026
Thereafter
Total	$ 25,509

Schedule of Assets underlying O

Schedule of Assets underlying Operating Leases (Details)	Jun. 30, 2023 USD ($)
Accounting Policies [Abstract]
PrintRite3D Hardware	$ 77,208
Accumulated Depreciation	(12,445)
Net Book Value	$ 64,763

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Lease income from operating leases	$ 11,337	$ 28,343
Allowance for doubtful accounts receivable	$ 115,600	$ 115,600	$ 0
Underlying equipment useful life	7 years	7 years
Utility Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Utility patents usefull life	17 years	17 years

Schedule of Inventory (Details)

Schedule of Inventory (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Raw Materials	$ 257,714	$ 294,194
Work in Process	165,777	140,723
Finished Goods	516,543	516,026
Total Inventory	$ 940,034	$ 950,943

Summary of Definite-life Intang

Summary of Definite-life Intangible Assets and Accumulated Amortization (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Less: Accumulated Amortization	$ (89,712)	$ (74,716)
Net Intangible Assets	1,215,411	1,125,285
Provisional Patent Applications [Member]
Finite-Lived Intangible Assets [Line Items]
Patents	752,802	675,251
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Patents	$ 552,321	$ 524,750

Schedule of Aggregate Amortizat

Schedule of Aggregate Amortization Expense (Details)	Dec. 31, 2022 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2023 (Remaining)	$ 15,596
2024	31,192
2025	31,192
2026	31,192
Thereafter	353,437
Intangible asset and amortization expense	$ 462,609

Intangible Assets (Details Narr

Intangible Assets (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Amortization expense on intangible assets	$ 14,996	$ 10,993
Patent [Member]
Finite-Lived Intangible Assets [Line Items]
Costs relate to patents issued	$ 27,571

Schedule of Share Based Payment

Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)	6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Dividend yield	0%	0%
Risk-free interest rate	4.05%
Expected life	5 years	5 years
2020 Stock Appreciation Rights Plan [Member]
Dividend yield			0%
Risk-free interest rate
Expected volatility
Expected life			5 years
Risk-free interest rate, minimum			0.82%
Risk-free interest rate, maximum			2.79%
Expected volatility, minimum			108%
Expected volatility, maximum			119%
Minimum [Member]
Risk-free interest rate		0.95%
Expected volatility	100.23%	106.40%
Maximum [Member]
Risk-free interest rate		1.65%
Expected volatility	100.25%	110%

Schedule of Share Based Compens

Schedule of Share Based Compensation Stock Option Activity (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Equity [Abstract]
Number of Options, Outstanding, Beginning Balance	1,799,053	1,395,882
Weighted Average Exercise Price, Outstanding Beginning Balance	$ 3.76	$ 4.24
Weighted Average Remaining Contractual Life Years, Outstanding Balance	3 years 2 months 15 days	3 years 3 months 18 days	3 years 10 months 20 days
Aggregate Intrinsic Value, Outstanding, Beginning Balance
Number of Options, Granted	433,665	487,473
Weighted Average Exercise Price, Granted	$ 0.58	$ 2.50
Weighted Average Remaining Contractual Life Years, Granted	4 years 6 months 29 days	4 years 5 months 4 days
Aggregate Intrinsic Value, Granted
Number of Options, Exercised	0	0
Weighted Average Exercise Price, Exercised
Aggregate Intrinsic Value, Exercised
Number of Options, Forfeited or cancelled	(335,059)	(84,302)
Weighted Average Exercise Price, Forfeited or cancelled	$ 3.60	$ 4.39
Aggregate Intrinsic Value, Forfeited or cancelled
Number of Options, Outstanding, Outstanding Balance	1,897,659	1,799,053	1,395,882
Weighted Average Exercise Price, Outstanding Ending Balance	$ 3.07	$ 3.76	$ 4.24
Aggregate Intrinsic Value, Outstanding, Ending Balance
Number of Options, Expected to Vest in the Future Ending Balance	409,974
Weighted Average Exercise Price, Expected to Vest	$ 1.93
Weighted Average Remaining Contractual Life Years, Expected to Vest	4 years 10 days
Aggregate Intrinsic Value, Outstanding, Expected of Vest
Number of Options, Exercisable	1,487,685
Weighted Average Exercise Price, Exercisable	$ 3.38
Weighted Average Remaining Contractual Life Years, Exercisable	2 years 11 months 23 days
Aggregate Intrinsic Value, Outstanding, Exercisable
Number of Options, Vested, Exercisable and Options Expected to Vest Ending Balance	1,897,659
Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest	$ 3.07
Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest	3 years 2 months 15 days
Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest

Schedule of Stock Option Activi

Schedule of Stock Option Activity (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Outstanding, Beginning Balance	1,799,053	1,395,882
Weighted Average Exercise Price, Outstanding Beginning Balance	$ 3.76	$ 4.24
Weighted Average Remaining Contractual Life, Outstanding Balance	3 years 2 months 15 days	3 years 3 months 18 days	3 years 10 months 20 days
Aggregate Intrinsic Value, Outstanding, Beginning Balance
Number of Options, Granted	433,665	487,473
Weighted Average Exercise Price, Granted	$ 0.58	$ 2.50
Aggregate Intrinsic Value, Granted
Number of Options, Exercised	0	0
Weighted Average Exercise Price, Exercised
Aggregate Intrinsic Value, Exercised
Number of Options, Forfeited or cancelled	(335,059)	(84,302)
Aggregate Intrinsic Value, Forfeited or cancelled
Number of Options, Outstanding, Outstanding Balance	1,897,659	1,799,053	1,395,882
Weighted Average Exercise Price, Outstanding Ending Balance	$ 3.07	$ 3.76	$ 4.24
Aggregate Intrinsic Value, Outstanding, Ending Balance
Number of Options, Expected to Vest in the Future Ending Balance	409,974
Weighted Average Exercise Price, Expected to Vest	$ 1.93
Weighted Average Remaining Contractual Life, Expected to Vest	4 years 10 days
Aggregate Intrinsic Value, Outstanding, Expected of Vest
Number of Options, Exercisable	1,487,685
Weighted Average Exercise Price, Exercisable	$ 3.38
Weighted Average Remaining Contractual Life, Exercisable	2 years 11 months 23 days
Aggregate Intrinsic Value, Outstanding, Exercisable
Number of Options, Vested, Exercisable and Options Expected to Vest Ending Balance	1,897,659
Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest	$ 3.07
Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest	3 years 2 months 15 days
Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest
Stock Appreciation Rights [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Outstanding, Beginning Balance	1,157,787	370,624
Weighted Average Exercise Price, Outstanding Beginning Balance	$ 2.21	$ 3.15
Weighted Average Remaining Contractual Life, Outstanding Balance	3 years 7 months 17 days	4 years 2 months 26 days	4 years 1 month 9 days
Aggregate Intrinsic Value, Outstanding, Beginning Balance
Number of Options, Granted		814,862
Weighted Average Exercise Price, Granted		$ 1.81
Weighted Average Remaining Contractual Life, Granted		4 years 5 months 23 days
Aggregate Intrinsic Value, Granted
Number of Options, Exercised
Weighted Average Exercise Price, Exercised
Aggregate Intrinsic Value, Exercised
Number of Options, Forfeited or cancelled	(328,822)	(27,699)
Weighted Average Exercise Price, Forfeited or cancelled	2 years 1 month 6 days	2 years 10 months 28 days
Aggregate Intrinsic Value, Forfeited or cancelled
Number of Options, Outstanding, Outstanding Balance	828,965	1,157,787	370,624
Weighted Average Exercise Price, Outstanding Ending Balance	$ 2.26	$ 2.21	$ 3.15
Aggregate Intrinsic Value, Outstanding, Ending Balance
Number of Options, Expected to Vest in the Future Ending Balance	530,678
Weighted Average Exercise Price, Expected to Vest	$ 2.02
Weighted Average Remaining Contractual Life, Expected to Vest	3 years 10 months 6 days
Aggregate Intrinsic Value, Outstanding, Expected of Vest
Number of Options, Exercisable	298,287
Weighted Average Exercise Price, Exercisable	$ 2.68
Weighted Average Remaining Contractual Life, Exercisable	3 years 2 months 26 days
Aggregate Intrinsic Value, Outstanding, Exercisable
Number of Options, Vested, Exercisable and Options Expected to Vest Ending Balance	828,965
Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest	$ 2.26
Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest	3 years 7 months 17 days
Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest

Schedule of Warranty Activity (

Schedule of Warranty Activity (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Equity [Abstract]
Warrants Outstanding, Beginning Balance	3,823,279	3,987,931
Weighted Average Exercise Price Outstanding, Beginning Balance	$ 4.66	$ 6.10
Weighted Average Remaining Contractual Life Years,Ending Balance	2 years 4 months 2 days	1 year 2 months 8 days	2 years 1 month 6 days
Warrants, Granted	1,490,896
Weighted Average Exercise Price Outstanding, Granted	$ 0.58
Warrants,Exercised
Weighted Average Exercise Price Outstanding,Exercised
Warrants, Forfeited or cancelled	(2,412,086)	(164,652)
Weighted Average Exercise Price Outstanding, Forfeited or cancelled	$ 4.54
Weighted Average Remaining Contractual Life Years, Granted	2 years 7 months 13 days
Warrants Outstanding, Ending Balance	2,902,089	3,823,279	3,987,931
Weighted Average Exercise Price Outstanding,Ending Balance	$ 2.08	$ 4.66	$ 6.10

Stockholders_ Equity (Details N

Stockholders’ Equity (Details Narrative) - USD ($)				1 Months Ended	3 Months Ended			6 Months Ended		12 Months Ended
	Jan. 27, 2023	Jan. 26, 2023	Jan. 23, 2023	Jan. 31, 2020	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]
Preferred stock, shares authorized					10,000,000			10,000,000		10,000,000
Preferred stock, par value					$ 0.001			$ 0.001		$ 0.001
Preferred stock, shares issued					316	316		316		465
Preferred stock, shares outstanding					316	316		316		465
Options exercise price								$ 0.35
Number of shares granted								433,665		487,473
Allocation share based compensation expense					$ 138,489		$ 167,439	$ 363,339	$ 338,415
Unrecognized stock-based compensation expense, stock option					387,351			$ 387,351
Weighted average remaining recognition period								1 year 5 months 1 day
Directors [Member]
Subsidiary, Sale of Stock [Line Items]
Vesting percentage								50%
Directors [Member] | December 31, 2022 [Member]
Subsidiary, Sale of Stock [Line Items]
Vesting percentage								50%
19 Employees [Member]
Subsidiary, Sale of Stock [Line Items]
Vesting percentage		50%
Number of shares granted		381,285
Option strike price		$ 0.58
2020 Stock Appreciation Rights Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Options exercise price								$ 0.35
Unrecognized share based compensation cost					$ 474,228			$ 474,228
Weighted average remaining recognition period								1 year 9 months
Employee Retention Agreements [Member] | 2020 Stock Appreciation Rights Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Options exercise price		$ 0.58
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Number of stock issued converted during period, shares								230,015
Series D Convertible Preferred Stock [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Conversion of stock, shares converted						132
Number of shares as in-kind payment, shares						43,241
Series E Convertible Preferred Stock [Member] | Other Securities Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Conversion of stock, shares converted								48,544
Share issued and sold during period, shares								333
Dividend rate								9%
Series E Convertible Preferred Stock [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Conversion of stock, shares converted						17
Number of shares as in-kind payment, shares						655
Series D Preferred Stock [Member] | Institutional Securities Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period	270,828
Preferred stock, par value				$ 1,000
Preferred stock, shares outstanding	132				0			0
Share issued and sold during period, shares				1,640
Dividend rate				9%
Conversion price per share				$ 0.58
Series E Preferred Stock [Member] | Institutional Securities Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period			3,083
Preferred stock, par value					$ 1,000			$ 1,000
Preferred stock, shares outstanding			17		316			316
Number of stock issued converted during period, shares								60,332
Private Placement [Member] | Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase shares of common stock		52,380
Private Placement [Member] | Series D Convertible Preferred Stock [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period						227,587
Private Placement [Member] | Series E Convertible Preferred Stock [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period						2,428

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - Subsequent Event [Member] - USD ($)		1 Months Ended
	Aug. 14, 2023	Jul. 31, 2023
Subsequent Event [Line Items]
Gross proceeds from slae of equipment		$ 135,000
Sales Agreement [Member]
Subsequent Event [Line Items]
Aggregate offering price	$ 1,500,000
Commission fee percentage	3%